Sommadossi Jean-Pierre sold AVIR
January 31, 2026 · Form 4 insider transaction
Sommadossi Jean-Pierre sold 173,466 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
173,466
Price
$0.00
Total value
N/A
InsiderSommadossi Jean-Pierre
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; The original grant of 520,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026.